New nugget – Achiko

[banana]

Good morning,

I'd love to hear your opinion on Achiko shares, listed on the Swiss stock exchange (CH0522213468).

I've got a good feeling about this little nugget. The share price is CHF 0.17.

The company recently changed its business sector to focus on covid testing.

This is a rapid, low-cost, saliva-based diagnostic test. It's a new procedure (DNA aptamer) that can also detect other diseases (dengue fever, for example).

Production is due to start up again this year, and the company's capitalization (CHF 20 million) is ridiculous. Analysts' target: CHF 1.- or x5!

Announcements this month or in December should catapult the share price. Graphically, it's attractive: the low is in place.

Further information here:

https://www.achiko.com/annonces?lang=fr

https://www.achiko.com/recherche?lang=fr

I smell gunpowder!

Personally, I bought several tens of thousands of shares at the end of last week. What do you think? New nugget?

 

[Jerome]

Hi,

Apparently it's a newly listed company with negative momentum and losses.

So it's a pure gamble on the future. I'm not saying you can't make money with it, but you can also lose a lot, and that's more of a lottery than an investment.

At least at this stage.

A++

[Thierry]

Good morning,

I always find it interesting to rewind to analyze the actual evolution of a stock compared to old predictions (or wishful thinking?) and try to understand what happened, whether you bought or not.

So far, the Achiko nugget has turned into a loss of almost 90%.
Thank you Jérôme 😉

[Jerome]

momentum rarely lies 😉

[Author]

Posts